NASDAQ:SPRY

Ars Pharmaceuticals Stock Forecast

etoro logo Buy SPRY
*Your capital is at risk
$5.76
-0.180 (-3.03%)
At Close: Jul 27, 2026
AI Analysis AI Analysis of SPRY AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add SPRY to Watchlist?
  • Easy Tracking In The Watchlist
PDF

ARS Pharmaceuticals, Inc. stock price down 3.03% on Monday
(Updated on Jul 27, 2026)

Sell candidate since Jul 13, 2026 Loss -25.58%

The ARS Pharmaceuticals, Inc. stock price fell by -3.03% on the last day (Monday, 27th Jul 2026) from $5.94 to $5.76. It has now fallen 10 days in a row. During the last trading day the stock fluctuated 7.83% from a day low at $5.62 to a day high of $6.06. The price has fallen in 10 of the last 10 days and is down by -25.58% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 2 million shares were bought and sold for approximately $10.45 million.

Given the current short-term trend, the stock is expected to fall -12.41% during the next 3 months and, with a 90% probability hold a price between $5.05 and $8.78 at the end of this 3-month period.

SPRY Signals & Forecast

There are few to no technical positive signals at the moment. The ARS Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.22 and $8.27. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, June 24, 2026, and so far it has fallen -45.35%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for ARS Pharmaceuticals, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.440 between high and low, or 7.83%. For the last week, the stock has had daily average volatility of 7.26%.

ARS Pharmaceuticals, Inc. is oversold on RSI14 (2). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SPRY) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect ARS Pharmaceuticals, Inc. to open at $5.81, and during the day (based on 14 day Average True Range), to move between $5.49 and $6.03, which gives a possible trading interval of +/-$0.536 (+/-9.75%) up or down from last closing price. If ARS Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 9.75% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $5.94, some $0.180 (3.13%) from the current price of $5.76, our system finds the risk reward not very attractive.

Is ARS Pharmaceuticals, Inc. stock A Buy?

ARS Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.768 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 28, 2026 - $5.81 ( 0.93%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

SPRY Performance

Trading levels for SPRY

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.25 8.56%
R2 6.09 5.65%
R1 5.98 3.84%
Price 5.76
S1 5.65 -1.99%
S2 5.54 -3.79%
S3 5.37 -6.71%

Accumulated Volume Support & Resistance Levels

Level Price
R3 6.36 10.42%
R2 6.06 5.21%
R1 5.94 3.13%
Price 5.76
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for ARS Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for ARS Pharmaceuticals, Inc. is SPRY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ARS Pharmaceuticals, Inc. Stock?
ARS Pharmaceuticals, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy ARS Pharmaceuticals, Inc. Stock?
ARS Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ARS Pharmaceuticals, Inc. Stock.

What's the current price of ARS Pharmaceuticals, Inc. Stock?
As of the end of day on the Jul 27, 2026, the price of an ARS Pharmaceuticals, Inc. (SPRY) share was $5.76.

What is the 52-week high and low for ARS Pharmaceuticals, Inc. Stock?
The 52-week high for ARS Pharmaceuticals, Inc. Stock is $18.63 and the 52-week low is $5.62.

What is the market capitalization of ARS Pharmaceuticals, Inc. Stock?
As of the Jul 27, 2026, the market capitalization of ARS Pharmaceuticals, Inc. is 571.987M.

When is the next earnings date for ARS Pharmaceuticals, Inc.?
The upcoming earnings date for ARS Pharmaceuticals, Inc. is Aug 12, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
TSCO
$30.32
4.88% Jul 23
IMMR
$6.60
17.20% Jul 23
S
SW
$43.71
14.60% Jul 23
KMT
$34.39
2.70% Jul 21
DHT
$17.31
5.66% Jul 13

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE